73,687 Shares in IonQ, Inc. $IONQ Purchased by Empowered Funds LLC

Empowered Funds LLC acquired a new position in IonQ, Inc. (NYSE:IONQ) in the second quarter, Holdings Channel.com reports. The institutional investor acquired 73,687 shares of the company’s stock, valued at approximately $3,925,000.

A number of other institutional investors and hedge funds have also modified their holdings of the company. Beaird Harris Wealth Management LLC raised its stake in shares of IonQ by 117.4% in the third quarter. Beaird Harris Wealth Management LLC now owns 500 shares of the company’s stock valued at $31,000 after purchasing an additional 270 shares in the last quarter. EFG International AG bought a new stake in IonQ in the 2nd quarter valued at $30,000. Accent Capital Management LLC increased its holdings in IonQ by 171.8% in the 4th quarter. Accent Capital Management LLC now owns 587 shares of the company’s stock valued at $26,000 after buying an additional 371 shares during the period. Kelleher Financial Advisors acquired a new position in shares of IonQ in the 3rd quarter valued at $36,000. Finally, Banque Transatlantique SA acquired a new position in shares of IonQ in the 3rd quarter valued at $43,000. 41.42% of the stock is currently owned by institutional investors.

Trending Headlines about IonQ

Here are the key news stories impacting IonQ this week:

• Positive Sentiment: Drug-discovery partnership validates IonQ’s technology. IonQ and QC Ware demonstrated a hybrid quantum-classical chemistry workflow using IonQ’s Forte trapped-ion system through Amazon Braket. The test produced enzyme active-site interaction-energy results within 4% of a benchmark, meeting the chemical-accuracy threshold cited for pharmaceutical research. The announcement expands IonQ’s potential applications beyond general quantum computing and could support future commercial demand. QC Ware and IonQ Demonstrate High-Precision Hybrid Quantum Workflow for Drug Discovery
• Positive Sentiment: IonQ’s platform is being integrated into advanced molecular modeling. QC Ware’s Promethium platform links GPU processing with IonQ Forte hardware, while access through Amazon Braket makes the workflow available through a major cloud-computing channel. This may improve IonQ’s visibility among pharmaceutical and enterprise customers. QC Ware and IonQ Demonstrate High-Precision Hybrid Quantum Workflow for Drug Discovery
• Neutral Sentiment: Analysts see substantial potential upside, but the target is not a new forecast catalyst. IonQ has a reported consensus price target of $69.92, well above the current trading range. However, the company remains unprofitable, with analysts expecting a full-year loss, so investors may require evidence that technical demonstrations translate into recurring revenue. IonQ Receives $69.92 Consensus Price Target from Analysts
• Negative Sentiment: Approaching warrant expiration raises dilution concerns. IonQ’s outstanding public warrants are scheduled to expire on September 30, 2026. Exercise of in-the-money warrants could provide cash to IonQ but increase the share count, potentially pressuring existing shareholders and contributing to near-term volatility. IonQ Warrants Expire September 30 as Investors Watch for Potential Dilution

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on IONQ. Benchmark reaffirmed a “buy” rating and set a $60.00 price objective on shares of IonQ in a report on Thursday, August 6th. Weiss Ratings lowered shares of IonQ from a “sell (d+)” rating to a “sell (d-)” rating in a research report on Friday, August 21st. Cantor Fitzgerald restated an “overweight” rating and set a $70.00 price target on shares of IonQ in a research note on Thursday, August 6th. Needham & Company LLC reaffirmed a “buy” rating and set a $65.00 price objective on shares of IonQ in a report on Thursday, August 6th. Finally, Wedbush initiated coverage on IonQ in a research note on Monday, August 3rd. They issued an “outperform” rating and a $75.00 price objective on the stock. Nine equities research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, IonQ has a consensus rating of “Moderate Buy” and an average price target of $69.92.

Insiders Place Their Bets

In related news, Director Gabrielle B. Toledano sold 2,757 shares of the firm’s stock in a transaction that occurred on Thursday, June 18th. The shares were sold at an average price of $55.01, for a total value of $151,662.57. Following the completion of the sale, the director owned 11,154 shares of the company’s stock, valued at $613,581.54. This trade represents a 19.82% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider John W. Raymond sold 3,815 shares of the business’s stock in a transaction that occurred on Thursday, June 18th. The stock was sold at an average price of $55.01, for a total transaction of $209,863.15. Following the completion of the transaction, the insider owned 80,148 shares of the company’s stock, valued at $4,408,941.48. This trade represents a 4.54% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders sold 9,329 shares of company stock valued at $513,216. Insiders own 0.55% of the company’s stock.

IonQ Stock Performance

Shares of NYSE:IONQ opened at $37.87 on Wednesday. The business has a fifty day moving average of $41.98 and a 200-day moving average of $43.48. IonQ, Inc. has a twelve month low of $25.89 and a twelve month high of $84.64. The firm has a market cap of $14.43 billion, a PE ratio of -8.13 and a beta of 3.30.

IonQ (NYSE:IONQ) last issued its quarterly earnings results on Wednesday, August 5th. The company reported ($0.33) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.56) by $0.23. IonQ had a negative net margin of 553.27% and a negative return on equity of 22.29%. The business had revenue of $80.05 million for the quarter, compared to the consensus estimate of $66.47 million. During the same quarter in the prior year, the company earned ($0.70) EPS. The firm’s quarterly revenue was up 286.7% on a year-over-year basis. On average, analysts anticipate that IonQ, Inc. will post -2.86 EPS for the current fiscal year.

IonQ Company Profile

IonQ, Inc engages in the development of general-purpose quantum computing systems in the United States. It sells access to quantum computers of various qubit capacities. The company makes access to its quantum computers through cloud platforms, such as Amazon Web Services (AWS) Amazon Braket, Microsoft’s Azure Quantum, and Google’s Cloud Marketplace, as well as through its cloud service. It also provides contracts associated with the design, development, and construction of specialized quantum computing hardware systems; maintenance and support services; and consulting services related to co-developing algorithms on quantum computing systems.